Eagle's Eye View: Your Weekly CV Update From ACC.org SGLT2 Inhibitors & Aortic Valve Stenosis; Early vs. Later Ablation for Afib; Sports Participation by Athletes with Cardiac Abnormalities
6 snips
Feb 26, 2025 Discover the intriguing potential of SGLT2 inhibitors to slow down aortic valve stenosis progression. Delve into the debate over whether early or late ablation is more beneficial for managing atrial fibrillation. Plus, learn about the new guidelines for athletes with cardiac abnormalities, emphasizing the importance of collaborative decision-making for safe sports participation.
AI Snips
Chapters
Transcript
Episode notes
SGLT2 Inhibitors and Aortic Stenosis
- SGLT2 inhibitors may slow aortic valve stenosis progression.
- This is based on an observational study, not a randomized trial.
Early vs. Late AFib Ablation
- Early AFib ablation may be better than later ablation, according to a Korean study.
- Early ablation was linked to lower cardiovascular event risks.
Sports Participation with Cardiac Abnormalities
- New guidelines suggest athletes with cardiovascular abnormalities can often safely participate in sports.
- Shared decision-making is crucial, considering risks and benefits.